Literature DB >> 19663890

Generation of NO by bystander human CD8 T cells augments allogeneic responses by inhibiting cytokine deprivation-induced cell death.

J C Choy1, J S Pober.   

Abstract

Nitric oxide (NO), generated by inducible NO synthase (iNOS) in bystander human CD8 T cells, augments the accumulation of allogeneically activated human CD8 T cells in vitro and in vivo. Here, we report that iNOS-derived NO does not affect T-cell proliferation but rather inhibits cell death of activated human CD8 T cells after activation by allogeneic endothelial cells in culture. Exogenous NO did not affect activation-induced cell death of human CD8 T cells but specifically reduced death of activated T cells due to cytokine deprivation. NO-mediated inhibition of T-cell death did not involve cGMP signaling, and NO did not affect the expression of Bcl-2-related proteins known to regulate cytokine deprivation-induced cell death. However, NO inhibited the activity of caspases activated as a consequence of cytokine deprivation in activated T cells. This protective effect correlated with S-nitrosylation of caspases and was phenocopied by z-VAD.fmk and z-LEHD.fmk, pharmacological inhibitors of caspases. In summary, our findings indicate that NO augments the accumulation of activated human T cells principally by inhibiting cytokine deprivation-induced cell death through S-nitrosylation of caspases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19663890      PMCID: PMC3505447          DOI: 10.1111/j.1600-6143.2009.02771.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  52 in total

Review 1.  Molecular mechanisms of activated T cell death in vivo.

Authors:  David A Hildeman; Yanan Zhu; Thomas C Mitchell; John Kappler; Philippa Marrack
Journal:  Curr Opin Immunol       Date:  2002-06       Impact factor: 7.486

2.  Nitric oxide preferentially induces type 1 T cell differentiation by selectively up-regulating IL-12 receptor beta 2 expression via cGMP.

Authors:  Wanda Niedbala; Xiao-Qing Wei; Carol Campbell; Duncan Thomson; Mousa Komai-Koma; Foo Y Liew
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-25       Impact factor: 11.205

Review 3.  T-lymphocyte death during shutdown of an immune response.

Authors:  Andreas Strasser; Marc Pellegrini
Journal:  Trends Immunol       Date:  2004-11       Impact factor: 16.687

4.  Activated T cell death in vivo mediated by proapoptotic bcl-2 family member bim.

Authors:  David A Hildeman; Yanan Zhu; Thomas C Mitchell; Philippe Bouillet; Andreas Strasser; John Kappler; Philippa Marrack
Journal:  Immunity       Date:  2002-06       Impact factor: 31.745

5.  Redox regulatory and anti-apoptotic functions of thioredoxin depend on S-nitrosylation at cysteine 69.

Authors:  Judith Haendeler; Jörg Hoffmann; Verena Tischler; Bradford C Berk; Andreas M Zeiher; Stefanie Dimmeler
Journal:  Nat Cell Biol       Date:  2002-10       Impact factor: 28.824

6.  T cell-mediated vascular dysfunction of human allografts results from IFN-gamma dysregulation of NO synthase.

Authors:  Kian Peng Koh; Yinong Wang; Tai Yi; Stephen L Shiao; Marc I Lorber; William C Sessa; George Tellides; Jordan S Pober
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

7.  Complexity of inducible nitric oxide synthase: cellular source determines benefit versus toxicity.

Authors:  Betty Y Poon; Eko Raharjo; Kamala D Patel; Samantha Tavener; Paul Kubes
Journal:  Circulation       Date:  2003-08-18       Impact factor: 29.690

8.  Identical alpha-chain T-cell receptor transcripts are present on T cells infiltrating coronary arteries of human cardiac allografts with chronic rejection.

Authors:  Bin Xu; Lazaros I Sakkas; Bruce I Goldman; Valluvan Jeevanandam; John Gaughan; Emilia L Oleszak; Chris D Platsoucas
Journal:  Cell Immunol       Date:  2003-10       Impact factor: 4.868

9.  Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/Apaf-1/caspase-9 apoptosome.

Authors:  Vanessa S Marsden; Liam O'Connor; Lorraine A O'Reilly; John Silke; Donald Metcalf; Paul G Ekert; David C S Huang; Francesco Cecconi; Keisuke Kuida; Kevin J Tomaselli; Sophie Roy; Don W Nicholson; David L Vaux; Philippe Bouillet; Jerry M Adams; Andreas Strasser
Journal:  Nature       Date:  2002-09-25       Impact factor: 49.962

10.  Nitric oxide-dependent mitochondrial biogenesis generates Ca2+ signaling profile of lupus T cells.

Authors:  Gyorgy Nagy; Maureen Barcza; Nick Gonchoroff; Paul E Phillips; Andras Perl
Journal:  J Immunol       Date:  2004-09-15       Impact factor: 5.422

View more
  6 in total

1.  Inflammatory cytokines determine the susceptibility of human CD8 T cells to Fas-mediated activation-induced cell death through modulation of FasL and c-FLIP(S) expression.

Authors:  Anna von Rossum; Randall Krall; Nichole K Escalante; Jonathan C Choy
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

Review 2.  Nitric oxide: promoter or suppressor of programmed cell death?

Authors:  Yiqin Wang; Chen Chen; Gary J Loake; Chengcai Chu
Journal:  Protein Cell       Date:  2010-02-06       Impact factor: 14.870

Review 3.  Participation of blood vessel cells in human adaptive immune responses.

Authors:  Jordan S Pober; George Tellides
Journal:  Trends Immunol       Date:  2011-10-24       Impact factor: 16.687

4.  Positive feedback regulation of human inducible nitric-oxide synthase expression by Ras protein S-nitrosylation.

Authors:  Martin Lee; Jonathan C Choy
Journal:  J Biol Chem       Date:  2013-04-18       Impact factor: 5.157

5.  Bim regulates alloimmune-mediated vascular injury through effects on T-cell activation and death.

Authors:  Anna von Rossum; Winnie Enns; Yu P Shi; Grace E MacEwan; Mehrnoush Malekesmaeli; Ryan Brinkman; Jonathan C Choy
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-04-03       Impact factor: 8.311

Review 6.  Regulation of T Cells in Cancer by Nitric Oxide.

Authors:  Inesa Navasardyan; Benjamin Bonavida
Journal:  Cells       Date:  2021-10-05       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.